AYA in RSC (n = 1,290) | AYA in non-RSC (n = 937) | p-value | |
---|---|---|---|
Age (years) | 22 (18–27) | 24 (20–28) | <0.001 |
[15–18] | 338 (26%) | 181 (19%) | <0.001 |
[18–25] | 539 (42%) | 390 (42%) | |
[25–30] | 413 (32%) | 366 (39%) | |
Gender, Male | 721 (56%) | 460 (49%) | 0.002 |
De novo metastatic disease | 149 (12%) | 89 (10%) | 0.172 |
Site of tumor a | <0.001 | ||
Bone sarcoma | 761 (59%) | 213 (23%) | |
Soft tissue sarcoma | 528 (41%) | 724 (77%) | |
Localisation | |||
Lower limbs tumors a | 633 (49%) | 244 (26%) | < 0.001 |
Tumor size (mm) b | 72 (47–110) | 50 (26–80) | < 0.001 |
Grade of tumor | < 0.001 | ||
Grade 1 | 79 (6%) | 50 (6%) | |
Grade 2 | 92 (7%) | 84 (10%) | |
Grade 3 c | 681 (54%) | 371 (42%) | |
Non gradable tumor | 401 (32%) | 368 (42%) |